Pfizer Covid 19 Vaccine
- All
- News
- Videos
- Photos
-
Pfizer To Test Third Dose Of Covid Vaccine For Children Below 5 Years
Pfizer announced Friday that it wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.
-
Germany Advises Against Moderna Covid Vaccine For People Under 30
German health authorities on Wednesday advised against the use of the Moderna coronavirus vaccine for people under 30 due to evidence of a small risk of cardiac inflammation.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Facebook Removes Russian Network That Targeted Influencers to Peddle Anti-COVID-19 Vaccination Messages
Facebook said it had removed a network of accounts from Russia that it linked to a marketing firm that aimed to enlist influencers to push anti-vaccine content about the COVID-19 jabs.
-
Britain To Offer COVID-19 Vaccine Shots To All 16 And 17 Year-Olds
Britain will offer all 16 and 17 year olds their first dose of Pfizer COVID-19 vaccine, Britain's vaccine advisers said on Wednesday, extending eligibility of the shots to children beyond the clinically vulnerable.
-
"Fill And Finish": Pfizer BioNTech To Produce COVID-19 Vaccines In South Africa
Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
"Should Procure Pfizer Vaccine ASAP For Children": Arvind Kejriwal
Delhi Chief Minister Arvind Kejriwal has called on the centre to procure the Pfizer COVID-19 vaccine to inoculate children in the national capital and across the country
-
Coronavirus India Highlights: Pfizer, Moderna Refuse To Sell Covid Vaccines To Delhi Government Directly: Arvind Kejriwal
Meanwhile, US pharmaceutical giants Pfizer and Moderna have made it clear they won't sell vaccines directly to Delhi, Chief Minister Arvind Kejriwal said today.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
After Pfizer, Moderna Begins COVID-19 Vaccine Rollout In US
US distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.
-
UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister
Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
YouTube to Add Link on COVID-19 Vaccines to Combat Misinformation
YouTube said it is adding a link to provide information on the development of COVID-19 vaccines to the coronavirus panel on its site, expanding its efforts to combat misinformation related to the pandemic.
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
-
Pfizer To Test Third Dose Of Covid Vaccine For Children Below 5 Years
Pfizer announced Friday that it wants to test a third dose of the Covid-19 vaccine in the under-fives, as the low dosage such small children can handle may not offer the same protection that older children enjoy from just two shots.
-
Germany Advises Against Moderna Covid Vaccine For People Under 30
German health authorities on Wednesday advised against the use of the Moderna coronavirus vaccine for people under 30 due to evidence of a small risk of cardiac inflammation.
-
Pfizer Jab Side Effects In 12-15 Year Olds Mild To Moderate: Study
A new study has revealed that the side effects of the Pfizer-BioNTech jab against COVID-19 in 12-15-year-olds at high risk of complications from the infection are likely to be mild to moderate.
-
Facebook Removes Russian Network That Targeted Influencers to Peddle Anti-COVID-19 Vaccination Messages
Facebook said it had removed a network of accounts from Russia that it linked to a marketing firm that aimed to enlist influencers to push anti-vaccine content about the COVID-19 jabs.
-
Britain To Offer COVID-19 Vaccine Shots To All 16 And 17 Year-Olds
Britain will offer all 16 and 17 year olds their first dose of Pfizer COVID-19 vaccine, Britain's vaccine advisers said on Wednesday, extending eligibility of the shots to children beyond the clinically vulnerable.
-
"Fill And Finish": Pfizer BioNTech To Produce COVID-19 Vaccines In South Africa
Covid vaccine makers BioNTech and Pfizer said Wednesday they would produce their jab in South Africa from 2022, a first for the continent that could see much-needed immunisation drives pick up speed.
-
Sanofi To Invest 400 Million Euros In A mRNA Vaccines Facility
The French drug giant and its British counterpart GlaxoSmithKline surprised investors and customers last year when they announced a one-year delay to the launch of their joint COVID vaccine, based on a more conventional technology.
-
"Should Procure Pfizer Vaccine ASAP For Children": Arvind Kejriwal
Delhi Chief Minister Arvind Kejriwal has called on the centre to procure the Pfizer COVID-19 vaccine to inoculate children in the national capital and across the country
-
Coronavirus India Highlights: Pfizer, Moderna Refuse To Sell Covid Vaccines To Delhi Government Directly: Arvind Kejriwal
Meanwhile, US pharmaceutical giants Pfizer and Moderna have made it clear they won't sell vaccines directly to Delhi, Chief Minister Arvind Kejriwal said today.
-
Pfizer Shot 97% Effective Against Symptomatic Covid: Study
Pfizer/BioNTech's coronavirus vaccine offers more protection than earlier thought with effectiveness in preventing symptomatic disease reaching 97 percent, according to real-world evidence published Thursday by the pharmaceutical companies.
-
After Pfizer, Moderna Begins COVID-19 Vaccine Rollout In US
US distribution of Moderna Inc's COVID-19 vaccine began on Saturday, with more than 3,700 sites due to start receiving and administering shots as soon as Monday, vastly widening the rollout started last week by Pfizer Inc.
-
UK Bets On Millions Of Pfizer-BioNTech Vaccine Doses This Year: Minister
Britain has used an emergency approval process to jump ahead of the EU and US in rollout plans of the vaccine
-
EU Health Agency To Meet By December 29 For Pfizer Covid-19 Vaccine Decision
The European Medicines Agency (EMA) on Tuesday said it would hold an extraordinary meeting on December 29 "at the latest" to consider emergency approval for a Covid-19 vaccine developed by Germany's BioNTech and US giant Pfizer.
-
YouTube to Add Link on COVID-19 Vaccines to Combat Misinformation
YouTube said it is adding a link to provide information on the development of COVID-19 vaccines to the coronavirus panel on its site, expanding its efforts to combat misinformation related to the pandemic.
-
Pfizer Soars 19% To All-Time High After Parent Company's Successful Vaccine Trials
Pfizer said its COVID-19 vaccine, developed in association with the German partner BioNTech SE, was more than 90 per cent effective against SARS-CoV-2.
